Table 1.
Group | Treatment | MOI | Transplanted cells | Irradiation (Gy) | N |
---|---|---|---|---|---|
1 | LV-GAAco/LV-IGF2.GAAco | 7 | 106 | 9 | 10 |
2 | LV-GAAco/LV-IGF2.GAAco | 2 | 106 | 9 | 10 |
3 | LV-GAAco/LV-IGF2.GAAco | 7 | 106 | 6 | 10 |
4 | LV-GAAco/LV-IGF2.GAAco | 2 | 106 | 6 | 10 |
5 | LV-GAAco/LV-IGF2.GAAco | 7 | 3 × 105 | 6 | 10 |
6 | LV-GAAco/LV-IGF2.GAAco | 2 | 3 × 105 | 6 | 10 |
7 | Untreated GAA−/− | 7 | NA | NA | 6 |
8 | Untreated WT | 2 | NA | NA | 6 |
MOI, multiplicity of infection; Gy, gray; Gaa−/− knockout; WT, FVB/N wild type; NA, not applicable.